Skip to main content

BPL 027 Pill: white, capsule/oblong

The pill with imprint BPL 027 (White, Capsule/Oblong, 0mm) has been identified as Flecainide Acetate 150 mg and is used for Atrial Fibrillation, Supraventricular Tachycardia, Paroxysmal Supraventricular Tachycardia, Ventricular Tachycardia, and Atrial Flutter. It belongs to the drug class group I antiarrhythmics and is not a controlled substance.

Images for BPL 027

Flecainide acetate 150 mg BPL 027

Flecainide Acetate

Imprint
BPL 027
Strength
150 mg
Color
White
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Group I antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bayshore Pharmaceuticals LLC
Manufacturer
Beximco Pharmaceuticals Ltd.
National Drug Code (NDC)
76385-0147

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.